Education and Professional Career
- 2018-2022 Postdoctoral Fellow, Advisor: Prof. Yiguang Wang
- 2015-2018 Ph.D. in Pharmaceutics, Peking University, Beijing, China (Advisor: Prof. Qiang Zhang and Prof. Yiguang Wang)
- 2013-2015 M.Sc. in Pharmaceutics, Peking University, Beijing, China (Advisor: Prof. Qiang Zhang)
- 2009-2013 B.Sc. in Pharmacy, Peking University, Beijing, China
Award and Honors
- 2021 Outstanding Postdoctoral Prize of Peking University
- 2018 National Postdoctoral Program for Innovative Talents of China Postdoctoral Foundation
Selected Publications
1. Chen BL, Yan Y, Yang Y, Cao G, Wang X, Wang Y, Wan F, Yin Q, Wang Z, Li Y, Wang L, Xu B, You F*, Zhang Q*, Wang YG*. A pyroptosis nanotuner for cancer therapy. Nature Nanotechnology. 2022, 17, 788-798.
2. Yan Y†, Chen BL†, Yin Q, Wang Z, Yang Y, Wan F, Wang Y, Tang M, Xia H, Chen M, Liu J, Wang S, Zhang Q, WangYG*. Dissecting extracellular and intracellular distribution of nanoparticles and their contribution to therapeutic response by monochromatic ratiometric imaging. Nature Communications. 2022, 13, 2004.
3. Chen BL†, Yang Y†, Wang Y, Yan Y, Wang Z, Yin Q, Zhang Q, Wang YG*. Precise Monitoring of Singlet Oxygen in Specific Endocytic Organelles by Super-pH-Resolved Nanosensors. ACS Applied Materials &Interfaces. 2021, 13, 18533-18544.
4. Chen BL†, Dai W†*, Mei D, Liu T, Li S, He B, He B, Yuan L, Zhang H, Wang X, Zhang Q*. Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system. Journal of Controlled Release. 2016, 241, 68-80.
5. Chen BL, Wang Z, Sun J, Song Q, Li S, He B, Zhang H, Wang X, Dai W*, Zhang Q*. A tenascin C targeted nanoliposome with navitoclax for specifically eradicating of cancer-associated fibroblasts. Nanomedicine:Nanotechnology, Biology, and Medicine. 2016, 12, 131-141.
6. Chen BL, Dai W*, He B, Zhang H, Wang X, Wang YG, Zhang Q*. Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment. Theranostics. 2017, 7, 538-558. (Highly cited paper)
7. Wang Y, Xia H, Chen BL*, Wang YG*. Rethinking nanoparticulate polymer-drug conjugates for cancer theranostics. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 2022, e1828.